Rayence Co., Ltd. (KOSDAQ:228850)

Verve Therapeutics Statistics

Total Valuation

Rayence has a market cap or net worth of KRW 103.39 billion. The enterprise value is -43.67 billion.

Market Cap	103.39B
Enterprise Value	-43.67B

Important Dates

The next estimated earnings date is Tuesday, August 12, 2025.

Earnings Date	Aug 12, 2025
Ex-Dividend Date	Dec 27, 2024

Share Statistics

Rayence has 15.74 million shares outstanding.

Current Share Class	15.74M
Shares Outstanding	15.74M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	4.97%
Owned by Institutions (%)	0.88%
Float	4.94M

Valuation Ratios

The trailing PE ratio is 28.01 and the forward PE ratio is 10.71.

PE Ratio	28.01
Forward PE	10.71
PS Ratio	0.88
PB Ratio	0.43
P/TBV Ratio	0.44
P/FCF Ratio	6.47
P/OCF Ratio	5.60
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-11.83
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2.73

Financial Position

The company has a current ratio of 12.98, with a Debt / Equity ratio of 0.02.

Current Ratio	12.98
Quick Ratio	10.65
Debt / Equity	0.02
Debt / EBITDA	0.86
Debt / FCF	0.34
Interest Coverage	1.59

Financial Efficiency

Return on equity (ROE) is 1.51% and return on invested capital (ROIC) is 0.20%.

Return on Equity (ROE)	1.51%
Return on Assets (ROA)	0.18%
Return on Invested Capital (ROIC)	0.20%
Return on Capital Employed (ROCE)	0.31%
Revenue Per Employee	513.54M
Profits Per Employee	16.19M
Employee Count	228
Asset Turnover	0.42
Inventory Turnover	2.07

Taxes

In the past 12 months, Rayence has paid 2.26 billion in taxes.

Income Tax	2.26B
Effective Tax Rate	37.98%

Stock Price Statistics

The stock price has decreased by -10.85% in the last 52 weeks. The beta is 0.58, so Rayence's price volatility has been lower than the market average.

Beta (5Y)	0.58
52-Week Price Change	-10.85%
50-Day Moving Average	6,726.00
200-Day Moving Average	6,608.50
Relative Strength Index (RSI)	46.36
Average Volume (20 Days)	32,203

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Rayence had revenue of KRW 117.09 billion and earned 3.69 billion in profits. Earnings per share was 234.56.

Revenue	117.09B
Gross Profit	43.33B
Operating Income	795.92M
Pretax Income	5.94B
Net Income	3.69B
EBITDA	6.27B
EBIT	795.92M
Earnings Per Share (EPS)	234.56

Balance Sheet

The company has 152.71 billion in cash and 5.38 billion in debt, giving a net cash position of 147.33 billion or 9,362.49 per share.

Cash & Cash Equivalents	152.71B
Total Debt	5.38B
Net Cash	147.33B
Net Cash Per Share	9,362.49
Equity (Book Value)	243.27B
Book Value Per Share	15,441.59
Working Capital	208.28B

Cash Flow

In the last 12 months, operating cash flow was 18.45 billion and capital expenditures -2.48 billion, giving a free cash flow of 15.97 billion.

Operating Cash Flow	18.45B
Capital Expenditures	-2.48B
Free Cash Flow	15.97B
FCF Per Share	1,015.15

Margins

Gross margin is 37.01%, with operating and profit margins of 0.68% and 3.15%.

Gross Margin	37.01%
Operating Margin	0.68%
Pretax Margin	5.08%
Profit Margin	3.15%
EBITDA Margin	5.35%
EBIT Margin	0.68%
FCF Margin	13.64%

Dividends & Yields

This stock pays an annual dividend of 100.00, which amounts to a dividend yield of 1.52%.

Dividend Per Share	100.00
Dividend Yield	1.52%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	42.63%
Buyback Yield	n/a
Shareholder Yield	1.52%
Earnings Yield	3.57%
FCF Yield	15.45%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Rayence has an Altman Z-Score of 4.62 and a Piotroski F-Score of 5.

Altman Z-Score	4.62
Piotroski F-Score	5